XML 31 R21.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value Assumptions The fair value of the option grants awarded during the nine-months ended September 30, 2024 was $0.1 million, which has been estimated with the following assumptions on the grant date.
Nine Months Ended September 30
2024
Risk-free interest rate
4.25%-4.61%
Volatility    
106.07% -123.31%
Expected life (years)    
5.00-6.00
Expected dividend yield    0%
Schedule of Stock Option Activity
The following table summarizes stock option activity for employees and non-employees for the nine months ended September 30, 2025 and 2024:
 Shares(1)Weighted-Average
Exercise Price(1)		Weighted-Average
Remaining
Contractual
Term (in years)
Outstanding at December 31, 2023
744 $2,853.60 7.26
Granted1,408 $45.30 
Exercised— 
Forfeited49 
Expired— 
Outstanding at September 30, 20242,103 $1,001.25 8.45
Exercisable at September 30, 2024606 $3,097.20 6.41
Outstanding at December 31, 20242,103 $1,001.25 8.20
Granted— $— 
Exercised— 
Forfeited— 
Expired— 
Outstanding at September 30, 20252,103 $996.13 7.46
Exercisable at September 30, 20251,951 $1,052.68 7.41
(1) and weighted average exercise price have been recast to reflect the 1-for-8 and 1-for-15 reverse stock split effected in June 14, 2024 and August 15, 2025, respectively.